Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Klümper

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
European Urology Focus|April 17, 2024
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial CancerNiklas Klümper, Markus Eckstein
Cancers|June 28, 2023
Insights into Urologic CancerNiklas Klümper, Jörg Ellinger
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Can NaCl predict or even enhance responses to immunotherapy in cancer?Jonas Saal, Michael Hölzel, Niklas Klümper
Cancer Research|December 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the LungsJonas Saal, Niklas Klümper, Michael Hölzel
Aktuelle Urologie|November 27, 2024
[Muscle-invasive and metastatic urothelial carcinoma from a pathological point of view]Niklas Klümper, Charis Kalogirou, Markus Eckstein
Aktuelle Urologie|July 1, 2025
[Current and future treatment stratification of metastatic urothelial carcinoma: a great opportunity for true precision oncology]Günter Niegisch, Stefanie Zschäbitz, Niklas Klümper, et al.
Urologie (Heidelberg, Germany)|January 28, 2026
[From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma]Günter Niegisch, Stefanie Zschäbitz, Markus Eckstein, et al.
JAMA Network Open|March 6, 2026
Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer SurvivalThomas Büttner, Niklas Klümper, Jörg Ellinger, et al.
European Urology|May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate CancerNiklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
American Journal of Translational Research|April 14, 2023
Depletion of the m<sup>6</sup>A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinomaWei Hu, Niklas Klümper, Doris Schmidt, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
European Urology Focus|April 17, 2024
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial CancerNiklas Klümper, Markus Eckstein
Cancers|June 28, 2023
Insights into Urologic CancerNiklas Klümper, Jörg Ellinger
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Can NaCl predict or even enhance responses to immunotherapy in cancer?Jonas Saal, Michael Hölzel, Niklas Klümper
Cancer Research|December 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the LungsJonas Saal, Niklas Klümper, Michael Hölzel
Aktuelle Urologie|November 27, 2024
[Muscle-invasive and metastatic urothelial carcinoma from a pathological point of view]Niklas Klümper, Charis Kalogirou, Markus Eckstein
Aktuelle Urologie|July 1, 2025
[Current and future treatment stratification of metastatic urothelial carcinoma: a great opportunity for true precision oncology]Günter Niegisch, Stefanie Zschäbitz, Niklas Klümper, et al.
Urologie (Heidelberg, Germany)|January 28, 2026
[From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma]Günter Niegisch, Stefanie Zschäbitz, Markus Eckstein, et al.
JAMA Network Open|March 6, 2026
Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer SurvivalThomas Büttner, Niklas Klümper, Jörg Ellinger, et al.
European Urology|May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate CancerNiklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
American Journal of Translational Research|April 14, 2023
Depletion of the m<sup>6</sup>A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinomaWei Hu, Niklas Klümper, Doris Schmidt, et al.
Pageof 10